NCT06788119 · RECRUITING
Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders
This trial tests whether adding a smartphone-based sensor tool called SYMPTOMS-JIT to standard cognitive behavioral therapy with in-person exposure exercises improves outcomes for people with anxiety disorders like phobias, panic disorder, and social anxiety. It is a Phase N/A trial, meaning it is studying a behavioral intervention rather than a drug — focused on whether this tech-assisted therapy works and how patients and therapists feel about it.
You may qualify if
- Being at least 18 years or older.
- Meeting DSM-5 diagnostic criteria (APA, 2013) for anxiety disorder, specifically specific phobia, agoraphobia, panic disorder and social phobia.
- Being willing to follow the study conditions.
- Sign the consent form.
You're excluded if
- Having another psychological problem that requires immediate attention.
- Having current alcohol or drug dependence or abuse, psychosis or severe organic illness.
- Currently being treated in a similar treatment program.
- Taking anxiolytics during the study (or in the case of taking them, changing drug or dose during the study).
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-05-16